Robot-Assisted Laparoscopic Myomectomy Is an Improvement Over Laparotomy in Patients With a Limited Number of Fibroids

This study has been completed.
Sponsor:
Information provided by:
Ascher-Walsh, Charles, M.D.
ClinicalTrials.gov Identifier:
NCT00910468
First received: May 28, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
  Purpose

This is a retrospective, case-control study of 75 patients having undergone a robotic-assisted laparoscopic myomectomy were compared to patients having undergone myomectomy via laparotomy. Both groups had 3 or fewer fibroids confirmed by pre-operative MRI or on final pathology report. Charts were reviewed for surgical and post-operative variables


Condition Intervention
Fibroid Uterus
Procedure: Robot-assisted Laparoscopic myomectomy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Robot-Assisted Laparoscopic Myomectomy Is an Improvement Over Laparotomy in Patients With a Limited Number of Fibroids

Resource links provided by NLM:


Further study details as provided by Ascher-Walsh, Charles, M.D.:

Primary Outcome Measures:
  • Post-operative variables, including estimated blood loss, length of stay, days to a regular diet and febrile morbidity [ Time Frame: 1 day ] [ Designated as safety issue: No ]

Enrollment: 150
Study Start Date: July 2005
Study Completion Date: July 2008
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Robot Assisted Laparoscopic Myomectomy Procedure: Robot-assisted Laparoscopic myomectomy
Robot-assisted Laparoscopic myomectomy
Myomectomy via Laparotomy

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Women with fibroid uterus desiring surgical management

Criteria

Inclusion Criteria:

  • uterus less than or equal to 20 weeks in size by office exam and no greater than three intramural fibroids on pre-operative MRI.

Exclusion Criteria:

  • significant medical problems limiting their ability to undergo a prolonged laparoscopic procedure and could not have had previous uterine surgery.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00910468

Locations
United States, New York
Mount SInai School of Medicine
New York, New York, United States, 10029
Sponsors and Collaborators
Ascher-Walsh, Charles, M.D.
Investigators
Principal Investigator: Charles Ascher-Walsh, MD, MPH Mt Sinai School of Medicine, Dept Obstetrics and Gynecology
  More Information

No publications provided

Responsible Party: Char;es Ascher-Walsh, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier: NCT00910468     History of Changes
Other Study ID Numbers: HSD08-00631
Study First Received: May 28, 2009
Last Updated: May 28, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Leiomyoma
Myofibroma
Neoplasms, Muscle Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Connective Tissue
Connective Tissue Diseases

ClinicalTrials.gov processed this record on July 20, 2014